Taylor Ben R 4

What Happened
Ben R. Taylor, Chief Financial Officer of Recursion Pharmaceuticals (RXRX), had 48,028 shares withheld in connection with the net settlement of restricted stock units to cover tax withholding. The filing shows the shares were valued at $3.11 each for a total of $149,367 and are reported as a disposition (code F — tax withholding).

Key Details

• Transaction date: 2026-04-06; Filing date: 2026-04-08 (appears timely — filed within the typical two-business-day window).
• Price per share: $3.11; Total value of shares withheld: $149,367.
• Transaction code: F (shares withheld to satisfy tax withholding).
• Footnote: F1 — shares were withheld by the issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
• Shares owned after transaction: not specified in the publicly available Form 4 entry.

Context
This was a routine net settlement of RSUs where the company withheld a portion of the award to cover taxes, not an open-market sale or new purchase. Such withholdings are common and generally reflect tax mechanics rather than an insider expressing a view on the stock.